Search
  • A2A Pharma

IndieBio

Updated: Feb 7, 2020

IndieBio - Designing Drugs insilico: An Interview with Ed Painter of A2A Pharmaceuticals


LEARN MORE

50 views0 comments

Recent Posts

See All

Biomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations in both hematologic and solid cancers, announced the closing of

Dr. Siddhartha Mukherjee, Dr. Annalisa Jenkins and Dr. Srikumar Chellappan join A2A’s Advisory Board. LEARN MORE